Delivery Order SPE2DB22D3301-SPE2DB25FX7KV

Award Date 12/19/24
Potential Completion Date 12/20/24
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX7KV
    Delivery Order

This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX7KV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,886.95 firm fixed-price delivery order is for the supply of 4,566,771,016 units of the medication Entecavir 0.5 mg Tablet in 30-count packages. The award has a completion date of December 20, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, to provide a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 3/20/25, 10:44 AM